THIRD AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 30, 2005 among WAMPOLE LABORATORIES, LLC and INVERNESS MEDICAL (UK) HOLDINGS LIMITED, as Borrowers, THE OTHER CREDIT PARTIES SIGNATORY HERETO, as Credit Parties, THE LENDERS SIGNATORY HERETO...Credit Agreement • July 7th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • New York
This THIRD AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”), dated as of June 30, 2005, is by and among INVERNESS MEDICAL INNOVATIONS, INC., a Delaware corporation (“Innovations”), WAMPOLE LABORATORIES, LLC, a Delaware limited liability company (“US Borrower”), INVERNESS MEDICAL (UK) HOLDINGS LIMITED, a company organized under the laws of England and Wales (“European Borrower”; US Borrower and European Borrower are sometimes collectively referred to as “Borrowers” and individually as a “Borrower”), the other Credit Parties signatory hereto, the Lenders signatory hereto from time to time, GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation, as administrative agent for Lenders, MERRILL LYNCH CAPITAL, a division of Merrill Lynch Business Financial Services Inc. (“ML Capital”), as documentation agent and co-syndication agent, UBS SECURITIES LLC, as co-syndication agent (“UBS Securities”), and GECC CAPITAL MARKETS GROUP, INC. and ML CAPITAL, as co-lead arrangers.
ASSET PURCHASE AGREEMENT dated as of May 28, 2005 by and amongAsset Purchase Agreement • July 7th, 2005 • Inverness Medical Innovations Inc • In vitro & in vivo diagnostic substances • Illinois
THIS ASSET PURCHASE AGREEMENT, dated as of May 28, 2005 is entered into by and among Abbott Laboratories, an Illinois corporation (“Abbott Laboratories”), Abbott Cardiovascular, Inc., a Delaware corporation (“Abbott Cardiovascular”), Abbott Japan Co., Ltd., a Japanese corporation (“Abbott Japan”, and collectively with Abbott Laboratories and Abbott Cardiovascular, “Seller”), on the one hand, and Inverness Medical Innovations, Inc., a Delaware corporation (“Parent”), Inverness Medical Switzerland GmbH, a corporation organized under the laws of Switzerland (“Inverness Switzerland”), and Inverness Medical Japan, Ltd., a corporation organized under the laws of Japan (“Inverness Japan”, and collectively with Parent, and Inverness Switzerland, the “Buyer”), on the other hand. Seller and Buyer sometimes are referred to in this Agreement collectively as the “Parties” and individually as a “Party”.
